INTRODUCTION
Brucellosis causes infertility and abortion in bovines (Radostits et al, 1994; Corbel, 1997) and undulant fever in humans (Corbel & Brinley-Morgan, 1984 ). Bovine brucellosis is usually caused by Brucella abortus, and less frequently by Brucella melitensis and Brucella suis (OIE, 1996) . Among the six recognized species of Brucella, B. abortus, B. melitensis, B. suis and Brucella canis can potentially infect humans (Nicoletti, 1980) while Brucella ovis and Brucella neotomae have not been isolated from humans.
Accurate diagnosis of brucellosis requires bacteriological isolation and detection of the pathogen in the laboratory, which is impractical for regular screening of large populations (Alton et aL, 1988; Lulu et al, 1988; Radostits et al., 1994; Yagupsky, 1994) . Serological tests can be nonspecific owing to cross-reaction or subsensitive or high immunity reactions, depending on subclinical or endemic prevalence of the disease 2000) or isolation have relied on single gene targets. The sensitivity and specificity of diagnostic assays can influence effective prevention and control of zoonoses as well as aid in selection of animals for breeding, etc. There are few comparative studies on the specificity of the different genus-specific PCRs and their correlation with serological diagnosis. This study analyses the sensitivity and specificity of the three established genusspecific PCRs of bcsp, omp2 and 16S rRNA gene sequences, and further evaluates their comparative efficiencies for the simple detection of the genus Brucella directly from blood samples, in a large-scale screening of individual animals from serologically positive Indian field buffaloes/ cattle herds. Further, a correlation between the diagnostic specificities of PCRs and an antibody-detecting blood ELISA is assessed employing kappa statistics.
METHODS
Brucella isolates and blood samples. Brucella strains were isolated from experimentally infected murines («=2), field isolates of human blood {«=4) and bovine milk (n=7) and uterine discharge (n-6). Bovine blood samples (n=87) used for serology and PCR studies were from two serologically positive herds of western India.
Source and maintenance of strains. The details of the origin of the standard strains are given in Table 1 . Brucella reference and field strains were identified and maintained as per the standard protocols (Alton et al, 1988) . Escherichia call ATCC 3616 was propagated on nutrient agar at 37 °C; Yersinia enterocolitica 0:3 and 0:9 were maintained on brain heart infusion agar (HI Media) at 28 °C; and Vibrio choleras 0:1 Inaba and Ogawa strains were grown on Terrestrial Yeast Extract medium at 25 °C (Baumann et al., 1984) . Mycobacterium tuberculosis H37Rv (ATCC 25618) was maintained on glycerol-supplemented L6wenstein-Jensen medium according to the ATCC Catalogue of Bacteria and Bacteriophages. Extraction of DNA from blood samples. DNA was extracted from bovine blood samples using a slight modification of a protocol published by Leal-Klevezas et al. (1995) . Heparinized blood (500 pi) was centrifuged at 1500 g for 3 min. Cell pellets were suspended in erythrocyte lysis buffer (155 mM ammonium chloride, 10 mM sodium bicarbonate, 100 mM disodium EDTA, pH 7.4) and centrifuged at 1500 g for 3 min; the cycle was repeated two to three times until the red colour due to the erythrocytes was minimal. The pellet was then treated with leukocyte lysis buffer (2% Triton X-100, 1 % sodium dodecyl sulfate, 100 mM NaCl, 10 mM Tris/HCl, pH 8.0), centrifuged at 3000 gfor 5 min and the pellet was digested with 10 pi proteinase K (10 mg ml-1) for 40 min at 50 "C. Following enzymic digestion, the samples were extracted with phenol/chlo roform and processed as above PCR assays. Three genus-specific PCR assays were performed for the identification of Brucella, (i) The PCR for the genus-specific Brucella cell surface salt extractable (BCSP) 31 kDa protein gene (Bricker et al., 1988; Mayfield et al., 1988) was performed on bacterial lysates and DNA extracts of isolates from experimentally infected mouse spleen, bovine blood and milk isolate samples, employing forward primer B4 (5' TGG CTC GGT TGC CAA TAT CAA 3') and reverse primer B5 (5' CGC GCT TGC CTT TCA GGT CTG 3') as described by Baily et al. (1992) .
(ii) The omp2 gene (GenBank accession no. M26034) (Fitch et al, 1989) was amplified from reference and field strains of Brucella in a 25 pi reaction mixture using primers JPF (5' GCG CTC AGG CTG CCG ACG CAA 3') and JPR (5' ACC AGC CAT TGC GGT CGG TA 3') as per Leal-Klevezas et al. (1995) . However, for amplification of DNA from field blood samples, the above protocol was modified by using 100 pmol of each primer and 4 mM Mg2+ in the PCR. AACACATGCAAGTCGAGCGCCCeGCAAGGG-GAGCGGCAGACGGGTGAGTA 77 AACACATGGAAGTCGAGCGCCCCGCAAGGG-GAGCGGAAGACGGGTGAGTA 77
AACACATGCAAGTCGAGCGCCCCGCAAGGG-GAGCGGCAGACGGGTGAGTA 7 7 ----------------------------TCGAGCGCCC-GCAAGGG--------------------------------------------------17
AACACATGCAACTCGAGCGCCC-GCAAGGGTGAGCGGCAGACGGGTGAGTA 100 ********** ******* fl>) 
---------------------------------------------TTAGTGGAGACACTATGGTT------------------------

Results of 16S rRNA PCR on blood samples
Although Mg2+ was elevated and the primer concentration increased to 1 pM, the 905 bp specific amplicon could not be detected directly from: any of the blood samples tested on repeated attempts under various PCR conditions, probably owing to the reasons described above. Hence the 16S rRNA was not used for comparison with bcsp and omp2 PCRs. The sensitivity of 16S rRNA primers has been previously reported to be affected by the presence of human DNA (Navarro et ah, 2002).
Correlation studies between bcsp and omp2 gene based blood PCR on field samples
The observed proportion of agreement (OPA=0.71 at P <0.05) was good and the degree of association (k=0.45 at P <0.05) was moderate between the two diagnostic blood PCR assays. The two PCR assays disagreed in 28.7% of cases ( Table 2 ). The bcsp was more sensitive as it could detect 24% more samples (21/87) as positive than omp2. Such a difference was not seen in PCR carried out on bacterial isolates. The present studies seemed to indicate that the presence of host DNA could affect the sensitivity of primers for the detection of Brucella in bovine blood as observed previously (Navarro et ah, 2002) . The sensitivity of the detection system could also be affected by bovine/buffalo blood samples from the field showed that although the overall proportion of agreement between the two tests (0.66 at P <0.05) was strong, the degree of association was weak (k=0.34 at P <0.05) ( Table 2 ). The PCR could detect 20.6 % more blood samples as positive compared to ELISA. Brucella genus specific sequence signatures were detected from 47 % (24/51) of serologically negative animals. Also this PCR was unable to detect Brucella in 6.8 % (6/87) of samples that were ELISA-positive.
Increased sensitivity of BCSP PCR over serology has been observed by Queipo-Ortuno et ah (2006) , where seroagglutination was inconclusive in 30 % of cases whereas real time PCR assay was positive in 90 % of samples of human brucellosis.
ELISA versus omp2-based PCR.
The omp2 gene could be amplified from blood samples by a modified PCR protocol. The 193 bp amplicon was obtained only after increasing the concentration of Mg2+ from 3.0 to 4.0 mM and that of the primers from 50 to 100 pmol in the reaction. The overall proportion of agreement (OPA=0.70 at P <0.05) and the degree of association (k=0.38 at P <0.05) between ELISA versus consensus of PCR based on bcsp and omp2. Only 62 out of 87 samples were screened by ELISA and bcsp and omp2 PCR. The consensus data of the bcsp and omp2 blood PCR showed the best overall proportion of agreement (OPA=0.74 at P <0.05) and a fanimprovement in the degree of association (k=0.5 at P <0.05) with ELISA as compared to ELISA versus bcsp or ELISA versus omp2-based PCR ( Table 2 ). The consensus of two PCRs identified 6% more samples (30/62) than ELISA (26/62) as positive and detected Brucella infection in 27.7 % (10/36) of animals that were serologically negative, but eliminated 9.7 % (6/62) animals that were ELISA-positive.
In the absence of the availability of an antigen-detecting ELISA we had used the antibody detection ELISA, widely used for serological monitoring programmes in India, despite the fact that antibody status did not always indicate disease under the chronic endemic situation that exists in the country. Evidence from human brucellosis indicates that the expression of anti-brucella antibodies does not correlate with the status of the disease (Elfaki et al., 2005). Therefore, we wanted to study how the degree of association (k value) between two tests systems was affected when the diagnostic gene targets in the PCR assays were altered. As observed in this study, the change in the gene target did not affect the nature or degree of association between ELISA and blood PCR. However, the closest and the best degree of statistical association (k=0.5 at P <0.05) was achieved when consensus results of bcsp and omp2 PCR were compared with those from ELISA. Therefore, we believe that consensus PCR is a more reliable diagnostic approach.
In an overall analysis of differential detection rates by ELISA and the two blood PCRs, the bcsp PCR was the most sensitive (92.72%) followed by omp2 PCR (61.81 %) and ELISA (55.55 %). These values were calculated taking into consideration that, in the absence of pathogen isolation, a positive PCR for bcsp or omp2 from the blood samples was regarded as a true indication of infection, as their specificities were confirmed by the PCRs on field isolates. Thus bcsp and omp2 PCRs together indicated 55 true infections (Table 2) , wherein bcsp showed maximum sensitivity (51/55). This assumption did not permit any consideration of false positive by PCR. Moreover, neither PCR gave false positives with non-brucella cultures. Thus both PCRs exhibited a specificity and positive predictive value of 100 % while ELISA showed 81.8 % specificity and 83.3% positive predictive value, bcsp PCR also gave a higher negative predictive value (88.88 %) than the omp2 PCR (61.81%) and ELISA (55.55%). Since anti-brucella antibodies do not always indicate disease, evaluation of ELISA was done using bcsp PCR results as a reference (Table 2) . ELISA was positive for 30 out of 54 bcsp-po.sitive samples, making it the least sensitive test. The consensus of PCRs detected 6 % more samples as positive than ELISA and perhaps it should be considered most specific, as it seemed to be neither under-nor over-detecting Brucella infection. The consensus of PCRs also seemed to show a low degree of failure since it was unable to detect infection on 9.7 % of occasions from ELISA-positive animals. Compared to the PCR consensus the omp2 system failed on 17.2 % occasions.
The most favourable factor regarding the omp2 PCR was that it had the best agreement of 78% (40/51) with the ELISA-negative samples in comparison to other PCR systems. We finally conclude that the use of more than one marker-based PCR gave increased sensitivity and higher specificity and appears to be a more reliable molecular diagnostic approach for screening of field animals.
/P economic significance in the country [3] , The prevalence of the infection in humans is directly related with the existence of the infection in animals. Since no effective vaccines are known for the prevention of human brucellosis, the only practical way to minimize the impact of the disease is to eradicate or control the infection in animals. Test and slaughter eradication programs cannot be applied in India and a mass vaccination program is the only reasonable alternative for controlling bovine brucellosis. The two live vaccines currently available for the prophylaxis of brucellosis in cattle are the B. abortus RB51 and the B. abortus S19 strains, the former allowing the differentiation of tests; The efficacy of the rough RB51 vaccine for the collective prophylaxis of brucellosis in ruminants is controversial [4] and, moreover, there is a lack of interest for this vaccine in countries which do not require differentiation of vaccinated and infected ani mals. The classical live and attenuated B. abortus S19 vaccine is considered as the best available vaccine for controlling brucellosis in cattle [2, 5, 6] and is the vaccine currently applied in India. The manufacture of B. abortus S19 vaccine is usually based on a seed lot system [7] , and it has been reported that inadequate subculture or maintenance of the seed strains can result in a loss of virulence and/or immunogenicity [8, 9] , Moreover, the different origin and the source and maintenance conditions of S19 seeds seem to be related to the final biological quality of S19 commercial vaccines [8] [9] [10] . Hence, before initiating a large-scale control program, it is advisable to examine the conformity to OIE rules [7] of the S19 vaccines to be used. It is also essential to establish the adequate identity patterns of the strain used by determining the appropriate markers for proper differentiation from B. abortus biovar 1 field isolates. The classical phenotypic markers used for such a purpose -i.e. inhibition of growth by penicillin, thionin blue and i-erythritol - [11] can show some degree of variability [9, 12] , and their value for differentiating S19 from the biovar 1 B. abortus field isolates needs to be confirmed by more specific tests. In this context, a characteristic 702 bp deletion in the ery gene has been demonstrated in SI9, and an associated PGR assay has been reported to be as highly specific for a quick and unequivocal differentiation of S19 from B.. abortus field strains [13, 14] . The objective of this work was to examine and compare the S19 strains used in India with reference S19 and virulent B. abortus strains by classical microbiological assays and molecular analysis of the ery loci, and to determine the virulence of these strains in BALB/c mice.
Materials and methods
2,1. Bacterial strains and culture conditions
The B. abortus S19 IVRI vaccine strain, used for commercial vaccine production in India, was obtained from the Indian Veterinary Research Institute (IVRI, Izatnagar, Uttar Pradesh, India). The strain was pro vided many years.-ago by the Central Veterinary Laboratory (GVL, Weybridge, UK) [15] , and it was maintained at the IVRI for years through subculture on potato infusion agar slants. The other commercial strain used (HR19 vaccine) was supplied by the local unit of Hoechst-Roussels Company (Germany) as freeze-dried commercial batches, containing 8-16 X 102 * * * * * * 9 colony forming units (CFU) per dose. The initial origin and maintenance of the seed used to obtain this HR 19 commercial vaccine is unknown. Freeze-dried batches of the three B. abortus S19 strains used as international reference (named NADL S19, USDA S19 and EU S19) were, respectively, obtained from the American Type Culture Collection (ATCC # 27565. This strain is not available anymore from the ATCC), the United States Department of Agriculture (USDA), and the European Union (Station de Pathologie Infectieuse ,et Immunite, INRA, France). The pathogenic B. abortus 544 biovar 1 reference strain was obtained from the American Type Culture Collection (ATCC # 23448; not currently available). ' -The HR19 strain was rehydrated in the diluent provided by the manufacturer and cultured on Tryptose agar (TA). The commercial IVRI and the reference NADL S19 strains were maintained by subculturing on potato infusion and tryptose (TA) agar, respectively. The freeze-dried vials containing the USDA S19 and the EU S19 reference strains as well as the virulent B. abortus 544 biovar 1 reference.strain were rehydrated in sterile Buffered Saline Solution (BSS; 0.15 M NaCl, 7 mM KH2P04, 10 mM K2HP04; pH 6.8) and in oculated onto TA or blood agar base (BAB) plates immediately before use. To obtain an adequate cellular mass for each test, the strains were sub cultured once on TA plates at 37 °C for 24-48 h.
Bacteriological analysis of S19 strains
Bacteriological characterization was performed ac cording to standard protocols [11] . Tests that discrim inate S19 from the reference B. abortus 544 biovar 1 strain were performed on TA or BAB plates supple mented either with Penicillin G (2.5 or 5 lU/ml), i-erythritol (1 mg/ml) or thionin blue (2 pg/ml) as described elsewhere [11] . The plates were incubated under both air and 10% C02 atmospheres.
The rate of spontaneous mutation to erythritol resistance was expressed as the ratio of the number of S19 CFU isolated on plates of agar supplemented with i-erythritol in relation to the number of S19 CFU obtained on plates of agar without added i-erythritol [9,16],
DNA extraction, primer designing and molecular assays
Seventy-two hours old cultures were washed twice in phosphate buffer saline (pH 6.4), pelleted by centrifu gation at 3000 X g for 20 min and suspended in 500 pi of Tris-EDTA buffer (pH 8.0). The suspended pellet was subjected to three cycles of snap freezing at -196 °C in liquid nitrogen and boiling at 95 °C for 10 min to obtain crude cell lysates. The lysates were sequentially treated with lysozyme (1 mg/ml) at 37 "Cfior 1 h, proteinase K (1 mg/ml) and sodium dodecyl sulphate 1% overnight at 50 °C. The lysates were subsequently extracted with standard phenokchloroform method, and the genomic DNA was precipitated, dried, suspended in 50 pi of TE and stored at 4 °C. DNA samples from B. abortus 2308 (another reference biovar 1 strain) and S19 of Spanish origin (obtained from the EU S19 strain) were kindly provided by Dr, Garcia-Lobo (University of Cantabria, Santander, Spain) for use as controls.
A PCR amplification of the genus-specific 31 kDa bcsp gene [17] was performed on purified Brucella DNA using B4 and B5 primers to generate specific 223 bp amplicons as described elsewhere [18] , Three ery locus specific PCR assays were performed: (i) the reference protocol [14] based on the 702 bp deletion-flanking forward primer (nt 75-94: 5' TTG GCG GCA AGT CCG TCG GT 3') and reverse primer (nt: 1137-1118: 5' CCC AGA AGC GAG ACG AAA CG 3') that generates 1063 bp and 361 bp amplicons from B. abortus biovar l strain and S19, respectively; (ii) a modification of an AMOS PCR [17] that results in a 178 bp amplicon from B. abortus field strains by a sense primer that anneals to the sequence common in S19 and B. abortus biovar 1 [nucleotide sequence (nt) 139-160:' 5' GCG CCG CGA AGA ACT TAT CAA 3'] at the 5' end of the gene and the anti-sense primer that anneals within the 702 bp deletion sequence (317-297 nt: 5' CGC CAT GTT AGC GGC GGT GA 3'); and (iii) an indigenous procedure developed in this work that used sense and anti-sense primer sequences from within the 702 bp deletion region. The sequence of the forward primer was 5'AGC TTC AGG ATC GGC TCA CC 3' (nt 282-301) and that of the reverse primer was 5' GAT GCA TTC GGT GAT GTC AC 3' (nt 895-876), both designed employing the Oligo 4.0 software and synthe sized commercially (Genset, Singapore). The reaction mixture for this procedure contained Mg2+ ions at 1.5 mM, primers at 0.2 pM concentration and 100 ng of target DNA. The reaction was carried out for 30 cycles of denaturation at 94 °C for 1 min, annealing at 58 °C for 30 s and extension at 72 °C for 30 s, and a final extension at 72 °C for 3 min. This indigenous procedure was expected to yield a 613 bp amplicon from only B. abortus biovar 1 field strains and yield a negative result when conducted with the S19 strains. The amplicons from all reactions were analysed by electrophoresis at 100 volts for 60 min in 1% agarose gel in TBE buffer.
For Southern hybridization, probes were prepared from locus specific amplicons, generated from the purified DNA of B. abortus 544 strain. The 178 bp and 613 bp amplicons generated, respectively, by the mod ified AMOS and the indigenous PCR procedures, were electro-eluted from 2% low-melting agarose gel and purified by standard phenol-chloroform-isoamyl alco hol method [19] . The amplicons were labelled with digoxigenin by PCR using DNA labelling and.detection 155 Kit (Roche, Germany). PCR amplicons from B. abortus 544 and S19 strains were electrophoresed on 1 % agarose gel, blotted on to nylon membrane, hybridized and detected according to kit instructions (DIG DNA labelling and detection kit Cat, No. 1093 657, Roche, Germany). A restriction enzyme map from the 1272 bp ery locus sequence [14] was generated (GENESIS software program) and enzymes Cla I and Apa I were selected to help confirm the sequence of the 1063 bp and 613 bp amplicons generated from the two PCR proce dures used.
Stability of molecular'markers after passage in Swiss mice
To assess the stability of the above molecular markers, groups of eight 10-week-old albino Swiss female mice were inoculated subcutaneously with 1 X 108 CFU of the two commercial strains tested, including a control group inoculated similarly with B. abortus 544. At 8 weeks post-ihfection, all animals were slaughtered, the spleens cultured and the corresponding isolates submitted to DNA extraction and molecular analysis as above.
Virulence studies in BALB/c mice
Groups of 20 female 9-week-old BALB/c mice were inoculated intraperitoneally with 1 X 105 CFU/mouse with each S19 strain. Mice inoculated with the EU S19 reference strain were considered as controls. Bacterial suspensions prepared were standardised by spectropho tometry as described elsewhere. [9] , and exact doses were assessed retrospectively by plating. Five mice from each infected group were slaughtered by cervical dislocation at 3, 6, 9 and 12 weeks post-inoculation, and the spleens were aseptically removed, individually weighed, and homogenized in nine volumes of BSS. Serial 10-fold dilutions of each homogenate were performed and each dilution was plated in triplicate onto BAB plates that were incubated at 37 °C for 5-7 days to determine the number of GFU/spleen. Bacterial growth curves of the infection caused by the corresponding S19 strains tested were represented graphically, entering the slaughtering time points (in weeks) in abscissas and the mean ± SD (n = 5) of individual logjo CFU/spleen in ordinates. The residual virulence (i.e. the time in weeks post-infection at which half of mice were estimated to be free from infection in spleens) of the S19 strains was expressed as the Recovery Time 50 (RT50) using the internationally recommended procedure [7] but considering those mice in which no S19 colonies were isolated in the portion of the spleen decimal dilution analysed (0.3 ml) as.cured. The RT50 values and the correspondent confidence limits as well .as the statistical comparisons for each S19 strain with respect to the EU S19 reference strain were performed by the Probit procedure of the recently developed "rev2" internet interface http://www.afssa.fr/ interne/rev2.html [20] and as recommended in [7] .
Results
Bacteriological analysis of B. abortus S19 strains
With the exception of the NADL S19 strain that was not inhibited by thionin blue in both the incubating atmospheres, all S19 strains tested demonstrated the microbiological markers characteristic of B. abortus biovar 1 as well as those specific for the S19 vaccine strain (Table 1) . No S19 strains required C02 for growth, and all were inhibited by penicillin G and ierythritol. However, as it has been described elsewhere [16, 21, 22] , all strains yielded different numbers of erythritol resistant colonies when cultured on medium containing /-erythritol. The growth of these erythritol resistant colonies was stimulated in . presence of C02 and the mutation rates for developing spontaneous ierythritol resistant colonies varied among strains, from low (1.33 X 10"7 for the EU S19) to high (1.42 X 10-2 for the HR19) ratios (Table 1) . '
Molecular, analyses of ery loci
PCR assays
The results of three different ery locus specific PCR protocols used for the analysis of S19 strains are shown in Fig; 1 and summarized in Table 2 . The S19 characteristic 702 bp deletion in the ery locus identified by the reference PCR protocol [14] was present only in the three S19 reference strains but, surprisingly, not in both HR19 and IVRI commercial vaccines. Accordingly, the S19 characteristic 361 bp amplicon (Fig. la) was only demonstrated in the three reference strains tested. Moreover, when the modified AMOS protocol [17] was used, the 178 bp amplicon typical of B. abortus field strains (Fig. lb) was absent from the three reference strains but not from the HR19 and IVRI commercial strains. Finally* the indigenous PCR procedure was unable to generate the 613 bp amplicon when applied to the three reference S19 strains (Fig. lc) but this amplicon was produced by B. abortus 544 and both commercial vaccine strains,
Analysis by Southern hybridization with ery locus
The above PCR results were confirmed by the Southern. hybridization of ery locus / specific PCR products with the digoxigenin labelled 178 bp and 613 bp probes from B. abortus 544 (Fig. 2 and Table 2 ). The amplicons from the virulent B. abortus .544 strain and both commercial vaccines but not the three S19 reference strains hybridized to these probes ( Fig. 2a  and b) .
Restriction enzyme analysis of ery locus specific amplicons
Restriction analysis of the 1063 bp amplicon with Cla I produced the expected 820 bp and 242 bp fragments .and digestion of the 613 bp amplicon with Apa I resulted ;in 494 bp and 119 bp fragments (Fig. 3) , thereby confirming the molecular integrity of the ery loci in the twocommercial S19 vaccine strains as well as in the B. abortus 544 virulent strain.
Stability of molecular markers after passage in Swiss mice
.
, : e.
All isolates from both S19 commercial strains, as well as the B. abortus 544 strain used as control, exhibited the same microbiological and molecular patterns before and after inoculation in Swiss mice (data not shown).
Virulence studies in BALB/c mice
:
The bacterial growth curves of splenic infections induced by the S19 strains tested at 3, 6, 9 and 1.2 weeks of post-infection are shown in Fig.. 4 . The bacterial growth curve obtained with the EU S19 reference strain, that is the control strain recommended, by the OIE [7] , was consistent with the typical growth curves obtained with good quality S19 vaccines [22, 23] . The USD A S19 Table I Results obtained'with the different B. abortus S19 vaccine strains tested in the classical microbiological tests [11] used to discriminate S19 from B. abortus biovar 1 field strains B. abortus strains HR19 IVRI S19 NADL S19 USDA S19 EU S19 544 Virulent
Growth in air/C02: Thionin blue (2 gg/ml)
RC/RC RC/RC RC/RC RC/RC RC/RC -/+ Mutation rate on medium containing /-erythritol3 1.4 X 10-2 1.1 X 1CT3 ' 1.3 X ICT6 2.5 X 1(T3 1.3 XTO-7. abortus NADL S19, USDA S19, Spanish S19 (EU S19), HR19 vaccine, and IVRI S19 vaccine, respectively. Lanes 2-7 (b and c): DNA extracts from B. abortus 544, B. abortus NADL S19, USDA S19, EU S19, HR19 vaccine, and IVRI Si9 vaccine. Lane 8 (b and c): water control.
reference strain induced a growth curve practically identical to that obtained with the EU S19 reference strain. By contrast, the NADL S19 reference strain and both the HR19 and IVRI S19 commercial vaccine strains induced bacterial growth curves that clearly indicated reduced virulence with respect to both USDA S19 and EU SI9 reference strains. During the first 6 weeks of infection, the three strains were recovered from spleens at significantly lower levels (1-3.4 logs below) than those obtained with both the USDA S19 and EU SI9 reference strains. At 9 weeks of post infection, clearance of infections in spleens took place in two out of five mice inoculated with HR 19 and IVRI S19 strains and four out of five mice inoculated with the NADL S19 strain, whereas, none of the mice inoculated with either USDA S19 or EU S19 reference strains was found to be free from infection. The loss of virulence of these three S19 strains was also evident when the residual virulence was analysed by means of RT50 values. These values and their corresponding confident ■ limits (in brackets) were 6.95 [5.19-8.71 ] weeks for both HR19 and IVRI commercial strains and 6.23 [4.15-8.21 ] weeks for the NADL S19 reference strain. By contrast, the RT50 value obtained for the USDA and EU reference strains was 9.28 [7.53-11 .05] weeks in both cases.
• . The isolates from mice spleen were submitted to bacteriological analysis as described in Section 2.2 to confirm if variations in the differential microbiological markers could have occurred after passage in mice. All strains showed the same microbiological characteristics as well as the molecular markers of the ery loci as before the inoculation (data not shown).
Discussion
Brucella abortus S19 strain can be bacteriologieally differentiated from the typical B. abortus biovar 1 field strains by its lack of C02 requirement for growth and its sensitivity to 5 lU/ml of Penicillin G, 1 mg/ml of ierythritoi and 2 pg/ml of thionin blue [11, 21] , All the strains tested had most of these classical differential characteristics (Table 1) , that were maintained after being passed through mice. However, the NADL S19 reference strain, while maintaining most of S19 The portion of the ery> locus sequence studied was derived from [14] and the restriction site map was generated through GENESIS software. a Sangari et al. [14] , b Bricker et al. [17] , c This paper (see Section 2): .
considered not adequate [8, 9] , could explain its reduced virulence in mice. The HR 19 commercial strain was apparently of European origin but the precise origin of the seed strain used and the precise conditions of preparation of this vaccine are unknown. It is also possible that HR 19 was also of British 19 origin, explaining the absence of the ery deletion and the similar reduced virulence in mice.
Is then the metabolism of erythritol important to virulence? The biochemical pathway of transformation of erythritol to 3-keto-L-erythrose 4-phosphate has been well described, and the genes of the ery operon that codes for the three enzymes responsible for this trans formation have been identified [24, 26] . It has been proposed that erythrose 4-phosphate, the precursor for the biosynthetic pathway for aromatic compounds in bacteria, might be easily obtained from the intermedi ates of the erythritol catabolism [24] , Thus, erythritol may be crucial to obtain molecules such as aromatic amino acids and catechols, which play important physiological roles in Brucella, providing a connection between erythritol metabolism and virulence in Brucella [24] , The absence in strain S19 of b-erythrulose-1 phosphate dehydrogenase (EryB), a critical enzyme in the erythritol catabolic pathway, causes the accumula tion of toxic intermediates D-erythrulose 1-phosphate and a.depletion of ATP, that results in the inhibition of bacterial growth [24, 27] , However, this inhibition is not complete. . ..Spontaneous erythritol tolerant mutants appear regularly, at different rates in SI9, depending on the source and maintenance of cultures [9,12,16,21, 28;29] , The genetic basis and biological consequences for erythritol tolerance has not been, fully elucidated [22, 24] . Existence of S19 spontaneous erythritol tolerant mutants has been reported that grow in the presence of this sugar but are unablerto oxidize it and retain the characteristic ery deletion as well as the characteristic residual virulence in guinea-pigs or mice [22, 32, 33] , suggesting a phenotypic restoration of the erythritol metabolic defect where the accumulation of intermediates is not toxic for the S19 spontaneous mutants.
: Erythritol utilization has been reported as a charac teristic of pathogenic B. abortus, strains [12, 21, [28] [29] [30] [32] [33] [34] [35] , The significant amount of erythritol detected in the placenta of ruminants has been suggested as the cause of specific localization and intense multiplication of B. abortus in this niche [35] . In fact, it has been reported that a relatively high percentage of S19 induced abortions in cattle were due to erythritol tolerant derivatives of S19 vaccine [28] [29] [30] [31] , All these data support the classically accepted hypothesis that there is a clear relationship between erythritol metabolism and Brucella virulence in animals. On the other hand, a spontaneous erythritol tolerant SI9 mutant and an erythritol resistant S19 mutant obtained by gene replacement, had the same virulence as the parental 15? erythritol sensitive S19 strain when inoculated in BALB/c mice [22] . Moreover, an erythritol sensitive mutant obtained from the virulent and erythritol, resistant B. abortus 2308 strain by transposon disruption of the ery gene [13] demonstrated the same virulence as that of its parental strain in BALB/c mice [22] . In the present work, both the EU S19 and USDA S19 reference strains induced bacterial growth curves in the spleens of mice [ Fig. 4) and RT50 values adequate for good quality S19 vaccines [7, 22, 23] . With the only exception of a high rafe of mutation to erythritol resistance by the USDA S19, both the other S19 trials demonstrated the genetic and microbiological markers typical of S19 (Tables 1 and 2 ; Fig. 1) . Thus, the different mutation rates in yielding spontaneous S19 erythritol resistant colonies appear to be unrelated with the genetic deletion or with virulence results in BALB/c mice. By contrast, both HR19 and IVRI commercial strains (lacking 702 bp deletion and showing high erythritol mutation rates) and the NADL reference strain (having this deletion but low erythritol mutation rates) showed a similar but clearly reduced virulence pattern in BALB/c mice when compared with both USDA and EU S19 reference strains (Fig. 4) . Thus, the relationship between the 702 bp ery deletion, the erythritol mutation rates and the virulence in mice of the different S19 strains tested cannot be established. Other mutational events unrelated to erythritol sensitivity taking place in both commercial vaccines and the NADL strain may explain their reduced virulence in mice and probably also the atypical behaviour of NADL strain when grown in the presence of thionin (Table 1) . It has been reported that reduced virulence in mice of both B. melitensis Rev .1 and B. abortus S19 living anti-Brucella vaccines can be the consequence of inadequate subculture or maintenance conditions, which could result in diverse unexpected mutations [9] . It has been recommended that vaccine seed lots showing reduced virulence in mice should not be used for vaccine production [7] [8] [9] . Thus, IVRI and HR19 commercial strains as well as the NADL reference strain did not fit with the characteristic patterns of B. abortus S19 strain and should not be used for vaccine production. The mere presence or absence of the 702 bp deletion in the ery locus of strains tested is unrelated with the rates of mutation to i-erythritol resistance and with the residual virulence in BALB/c mice. the semen PCR had a specificity of 75.92% but possessed a sensitivity of 76%. However it was also noticed that semen PCR can be used to consistently monitor brucellosis status in buffalo bulls over a period of time and that infection could be detected much earlier than ELISA.
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The optimized multiplex species-specific PCR correctly identified all reference strains but was unable to amplify the B. ovis DNA template. The species-specific PCR also recognized correctly Indian field strains from bovine, murine and human origin previously typed by classical methods as B. abortus and B. melitensis but the PCR was 78.94%
sensitive since it could not identify 6 out of 7 bovine milk isolates previously identified as
Brucella by culture as well as bcsp and omp2 specific PCRs.
Summary
The S19 vaccine strains exhibited diagnostic ambiguity with classical methods of typing and subsequent molecular analysis lead to some surprising and interesting observations. Two
Brucella abortus S19 commercial vaccine strains used for vaccination against brucellosis in India and three S19 strains available as international reference were examined by microbiological assays and molecular analysis of the ery loci involved in erythritol metabolism, and tested for residual virulence in BALB/c mice. The five strains tested had the phenotypic characteristics of strain SI9, according to the sensitivity to penicillin and /-erythritol. However, on culture medium containing /-erythritol, all strains developed spontaneous z-erythritol resistant colonies at mutation rates ranging from 1.42 x 10-2 to 1.33
x 10-6. The S19 characteristic 702 bp deletion in the erythrulose 1-phosphate dehydrogenase gene of the ery locus was present only in the three reference strains but not in the two commercial vaccines. Both commercial strains and one of the reference strains showed reduced virulence in BALB/c mice. The presence or absence in S19 strains of the 702 bp deletion in the ery locus had no correlation with either the rates of spontaneous mutation to erythritol resistance or the residual virulence in mice.
Since the ery locus specific PCR was not able distinguish all the SI9 vaccine strains available globally from wild type B. abortus 544, search for additional DNA markers was performed by employing three approaches; suppressive subtractive hybridization (SSH) using a commercial kit, analysis with variable nucleotide terminal repeats (VNTR) using a multi-locus PCR format and search for the presence or absence of known virulence genes and their regulators by PCR and RT-PCR.
Diagnostic tests conducted as per the recommendations of the commercial SSH kit for determining the efficiency of the subtraction between the 'driver' NADL SI9 and the 'tester' B. abortus 554 indicated that all genes may not have been subtracted with same efficacy.
Slot-blot hybridization of purified PCR products from the 54 clones in the subtracted library using B. abortus 544 tester and NADL S19 strain probes and stringency washes at 68 °C Five of the 14 tester-specific clones (17, 23, 25, 26 and 111) were validated by PCR amplification of 'tester' 544 and 'driver' NADL S19 genomic DNA templates with clone-specific primers. PCR results indicated that amplicons from strains 544 and NADL S19 corresponding to only clone 26 differed slightly in the electrophoretic mobility. Subsequent sequencing of the five pairs of amplicons and a four way comparison of these sequences from strains 544 & NADL S19 and those of strains 9-941 & 2308 available in the public domain using multiple sequence alignment tool (CLUSTAL W) were undertaken. Multiple sequence alignment indicated differences among four strains in sequences corresponding to 4 out of 5 clones. Only minor differences in the nucleotide sequence as 1-2 bp mismatches/gaps were observed between strains 544 and NADL SI9. Mostly the mismatches/gaps were found in the NADL SI9. PCR using clone specific primers was unable to discriminate USDA S19, IVRI S19 and the B. abortus field strain on the basis of agarose electrophoresis profiles.
The detection of tester strain 544 specific clones by the differential hybridization and yet the absence of major differences between strains 544 and S19 in the corresponding sequences generated by internal clone-specific primers could be ascribed to the selection of primers for amplification that did not represent the flanks of tester-specific sequence resulting in loss of sequence information from the flanking region. Weak hybridization signals had been observed when some of the tester-specific clones were hybridized with the 'driver' strain probe. Multi-copy genes harbored by Bucella abortus in chromosome I and II have been reported in the literature. Hence differences in gene copy number between the B. abortus tester and driver strains and not presence or absence of gene might produce weak hybridization signals with 'driver' strain probe as observed.
Two of the 14 clones-24 and 111-identified as tester specific were also found to be different in USDA S19 when compared with 9-941 and 2308 (Crasta et al., 2008) . Another tester specific clone USDA S19 when sequence generated with adapter based primers PI and 2R where used amplify the 12 tester specific clones.
It can be concluded that SSH was not so effective as compared to sequencing in detecting small insertions /deletions or differences of the order of 1-2 bp. The validation of SSH was also affected by choice clone-specific primers which were not representative of the flanking°£ regions. Further minor differences in the size clone^specific amplicons from strains 544 and NADL S19 cannot be detected by agarose gel electrophoresis.
Taking advantage of the sequence information on variable number tandem repeats (VNTR) of the Brucella genome the PCR approach based on 21 loci multiplex PCR Brucella strain differentiation tool identified at least 8 out 21 loci that could differentiate strain 544 from strain NADL S19 on the sets of specific allele profiles. However forjudging the differences between strains the composite PCR profiles of all the 21 loci needed consideration rather than an individual allele specific profile. For example the allele specific profile generated from VNTR 12b clearly differentiated the 544, NADL S19, USDA S19, IVRI S19 and the field strain B. abortus 18/98 but alone was considered a risky interpretation because of high plasticity of the region.
Further, differentiation of strains on the basis of presence or absence genes related to virulence by PCR or difference in gene expression by RT-PCR was studied using 6-7 gene
targets. An RT-PCR on cDNA templates amplified a 394 bp specific region from the VirB4 of B. abortus 544 but not from other S19 strains. Also, one of the gene from the host two component regulatory system BvrR could be amplified from 544 wild type and other SI9 strains except the IVRI S19.
